Dietary Supplements Adulterated with Drugs and Contaminated with Heavy Metals
- 1 January 2025
- book chapter
- Published by Springer Nature
- p. 331-345
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Elemental impurities (heavy metals) in kratom products: an assessment of published individual product analysesClinical Toxicology, 2024
- Recalls, Availability, and Content of Dietary Supplements Following FDA Warning LettersJAMA, 2022
- Continued Risk of Dietary Supplements Adulterated With Approved and Unapproved Drugs: Assessment of the US Food and Drug Administration's Tainted Supplements Database 2007 Through 2021The Journal of Clinical Pharmacology, 2022
- Phosphodiesterase 5 (PDE5): Structure-function regulation and therapeutic applications of inhibitorsBiomedicine & Pharmacotherapy, 2020
- Pharmacologic and clinical assessment of kratom: An updateAmerican Journal of Health-System Pharmacy, 2019
- Unapproved Pharmaceutical Ingredients Included in Dietary Supplements Associated With US Food and Drug Administration WarningsJAMA Network Open, 2018
- The FDA and Adulterated Supplements—Dereliction of DutyJAMA Network Open, 2018
- Discontinuation of Dapoxetine Treatment in Patients With Premature Ejaculation: A 2-Year Prospective Observational StudySexual Medicine, 2017
- Lead, Mercury, and Arsenic in US- and Indian-Manufactured Ayurvedic Medicines Sold via the InternetJAMA, 2008
- Baroreflex Buffering and Susceptibility to Vasoactive DrugsCirculation, 2002